Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4 (ECZema TRAlokinumab Trial no. 4)

Condition:   Atopic Dermatitis Interventions:   Drug: Tralokinumab;   Drug: Caffeine;   Drug: Warfarin;   Drug: Omeprazole;   Drug: Metoprolol;   Drug: Midazolam Hydrochloride Sponsor:   LEO Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials